Jordan E Axelrad1, Ken H Cadwell1,2, Jean-Frederic Colombel3, Shailja C Shah4. 1. Division of Gastroenterology, Department of Medicine, NYU School of Medicine, New York, NY, USA. 2. Department of Microbiology, NYU School of Medicine, New York, NY, USA. 3. Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Division of Gastroenterology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract
BACKGROUND: The initiating events of chronic gastrointestinal (GI) inflammation in Crohn's disease (CD) and ulcerative colitis (UC) are not well-defined, but GI infections are implicated. AIMS: To define the role of GI infections in risk of incident inflammatory bowel disease (IBD) and synthesise the current body of relevant translational data to provide biological context for associations between GI infections and IBD risk. METHODS: We systematically reviewed electronic databases through February 2020. Clinical studies that provided risk estimates of the association between GI infections and incident IBD were included. Inclusion criteria were broader for translational studies aiming to define mechanisms of GI infections and predisposition to or protection from IBD. RESULTS: Of the studies identified, 63 met full inclusion criteria. Among studies of clinical gastroenteritis, bacteria-specifically, Salmonella species, Campylobacter species and Clostridioides difficile-demonstrated consistent positive associations with risk of incident IBD. Of viruses, norovirus was associated with increased risk of incident CD. Regarding inverse associations with incident IBD, Helicobacter pylori and helminth infections were associated with a generally consistent reduced risk of IBD. Based on a qualitative analysis of the translational data, putative mechanisms involve multiple microbial and immunologic pathways. CONCLUSIONS: Based on this systematic review, certain enteric pathogens are associated with an increased risk of incident IBD, while others are potentially protective. Prospective studies are required to clarify the clinical implications of these enteric pathogens on the risk and course of IBD, and possible therapeutic or preventative benefit.
BACKGROUND: The initiating events of chronic gastrointestinal (GI) inflammation in Crohn's disease (CD) and ulcerative colitis (UC) are not well-defined, but GI infections are implicated. AIMS: To define the role of GI infections in risk of incident inflammatory bowel disease (IBD) and synthesise the current body of relevant translational data to provide biological context for associations between GI infections and IBD risk. METHODS: We systematically reviewed electronic databases through February 2020. Clinical studies that provided risk estimates of the association between GI infections and incident IBD were included. Inclusion criteria were broader for translational studies aiming to define mechanisms of GI infections and predisposition to or protection from IBD. RESULTS: Of the studies identified, 63 met full inclusion criteria. Among studies of clinical gastroenteritis, bacteria-specifically, Salmonella species, Campylobacter species and Clostridioides difficile-demonstrated consistent positive associations with risk of incident IBD. Of viruses, norovirus was associated with increased risk of incident CD. Regarding inverse associations with incident IBD, Helicobacter pylori and helminth infections were associated with a generally consistent reduced risk of IBD. Based on a qualitative analysis of the translational data, putative mechanisms involve multiple microbial and immunologic pathways. CONCLUSIONS: Based on this systematic review, certain enteric pathogens are associated with an increased risk of incident IBD, while others are potentially protective. Prospective studies are required to clarify the clinical implications of these enteric pathogens on the risk and course of IBD, and possible therapeutic or preventative benefit.
Authors: Yun-Gi Kim; Nobuhiko Kamada; Michael H Shaw; Neil Warner; Grace Y Chen; Luigi Franchi; Gabriel Núñez Journal: Immunity Date: 2011-05-12 Impact factor: 31.745
Authors: Wendy S Garrett; Carey A Gallini; Tanya Yatsunenko; Monia Michaud; Andrea DuBois; Mary L Delaney; Shivesh Punit; Maria Karlsson; Lynn Bry; Jonathan N Glickman; Jeffrey I Gordon; Andrew B Onderdonk; Laurie H Glimcher Journal: Cell Host Microbe Date: 2010-09-16 Impact factor: 21.023
Authors: Toshio Arai; Fernando Lopes; Adam Shute; Arthur Wang; Derek M McKay Journal: Am J Physiol Gastrointest Liver Physiol Date: 2018-01-04 Impact factor: 4.052
Authors: Jay Luther; Stephanie Y Owyang; Tomomi Takeuchi; Tyler S Cole; Min Zhang; Maochang Liu; John Erb-Downward; Joel H Rubenstein; Chun-Chia Chen; Anna V Pierzchala; Jose A Paul; John Y Kao Journal: Gut Date: 2011-04-06 Impact factor: 23.059
Authors: Mara Jana Broadhurst; Amir Ardeshir; Bittoo Kanwar; Julie Mirpuri; Uma Mahesh Gundra; Jacqueline M Leung; Kirsten E Wiens; Ivan Vujkovic-Cvijin; Charlie C Kim; Felix Yarovinsky; Nicholas W Lerche; Joseph M McCune; P'ng Loke Journal: PLoS Pathog Date: 2012-11-15 Impact factor: 6.823
Authors: Hamed Khalili; Jordan E Axelrad; Bjorn Roelstraete; Ola Olén; Mauro D'Amato; Jonas F Ludvigsson Journal: Gastroenterology Date: 2021-01-06 Impact factor: 22.682
Authors: Jordan E Axelrad; Ken H Cadwell; Jean-Frederic Colombel; Shailja C Shah Journal: Therap Adv Gastroenterol Date: 2021-03-31 Impact factor: 4.409
Authors: Won Ho Yang; Julia S Westman; Douglas M Heithoff; Markus Sperandio; Jin Won Cho; Michael J Mahan; Jamey D Marth Journal: Proc Natl Acad Sci U S A Date: 2021-07-20 Impact factor: 11.205